GLP-1 agonists produce dramatic weight loss (averaging 15-20% total body weight) primarily through central appetite suppression, eliminating hunger and creating pharmaceutical satiety
Physical therapy and exercise programs may become more effective when combined with BPC-157 therapy
Read review Dihexa for OCD HGF/GABA biology, Russo 2013, troriluzole BHV-4157 failure, psilocybin COMP360, and the 750,000 UK OCD population
Now, we don't know exactly how much overlap exists between heavy drinkers and GLP-1 users, but given that this group consumes thousands of extra liquid calories per week, I think it's reasonable to assume high rates of overweight and obesity in this group
To neutralize ROS, cells induce various antioxidant systems, including the activation of the protein machinery that produces glutathione [10], the most abundant antioxidant scavenger in all cells [11, 12]